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ABSTRACT 
6–Thioguanine (1a) is considered to be photochemotherapeutic agents due to its specific 
characteristics of photosensitivity to UVA light and singlet molecular oxygen generation. To 
extend its phototherapeutic ability, two related thioguanines, 8–thioguanine (2a) and 
6,8–dithioguanine (3a), have been designed and explored. Since the solubility of these 
thioguanines in dehydrated organic solvents is too poor to study, their tri–acetyl–protected 
ribonucleosides, i.e. 2’,3’,5’–tri–O–acetyl–6–thioguanosine (1c), 
2’,3’,5’–tri–O–acetyl–8–thioguanosine (2c) and 2’,3’,5’–tri–O–acetyl–6,8–dithioguanosine 
(3c) were prepared and investigated. The absorption maxima of 1c, 2c and 3c in acetonitrile 
were found at longer wavelengths than that of un–thiolated guanosine (4c). Especially, 3c has 
the longest wavelength for absorption maximum and the highest value in terms of molar 
absorption coefficient among all thio–nucleobases and thio–nucleosides reported. These 
absorption properties were also well reproduced by quantum chemical calculations. Quantum 
yields of singlet oxygen generation of 2c and 3c were determined by near–infrared emission 
measurements to be as large as that of 1c. These results suggest that the newly synthesized 
thioguanosines, in particular 3c, can be further developed as a potential photosensitive agent 
for light–induced therapies. 
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INTRODUCTION 
6–Thioguanine (1a, see Scheme 1) and other thio–analogues of natural nucleobases have 
high affinity to proliferating cells, and some of them have been prescribed for the treatment 
of cancers, leukemia and angina among others (1–9). 1a can be converted into 
6–thioguanosine (1b) through cellular metabolism, followed by being incorporated into RNA 
and DNA (1–6,10,11). O’Donovan et al. reported that 1a localizing in tumor cell generated 
reactive oxygen species (ROS) by its exposure to UVA light and thus cellular apoptosis was 
induced (8). These findings indicate that 1a and its nucleosides could be used as an effective 
medical tool for cancer treatment due to their unique properties as photochemotherapeutic 
drugs like 4–thiothymidine, including a photoactivatable genotoxic agent and a 
photosensitizer for photodynamic therapy (PDT), in addition to the hitherto known use as an 
anticancer medicine (5,9,12,13). 
 
>Scheme 1< 
 
As a photochemotherapeutic agent, the photosensitizer must be sensitive to the light 
penetrating into deep hypodermal tissue and can also effectively generate singlet oxygen 
(
1
O2
*
), one type of ROS. In the ultraviolet and visible light region, the longer wavelength 
light has higher permeability to subcutaneous tissues (14). However, the absorption maxima 
of 1a and 1b have been observed at around 350 nm, which is not long enough to allow the 
light to penetrate into deep subcutaneous tissues (3,15–20). Thus, it is well worth designing 
and developing alternative thioguanines and their nucleosides with an absorption band at 
longer wavelengths. 
Photophysical and photochemical properties of 2a, 3a and their nucleosides (2b and 3b) 
have not been documented although their synthetic studies were reported (21–24). 
8–Oxoguanine (with a carbonyl group at 8–position of the purine ring and also known as an 
oxidation photoproduct of guanine (4a)), was reported to exhibit a red–shifted absorption 
band relative to its 6–oxo–analogues (4a and 4b) (25–27). As well as 1a and 1b, 
thiocarbonyl–modified pyrimidine bases (such as thiolated–uracil and –thymine), have a 
strong absorption maximum at longer wavelength than their respective un–thiolated 
nucleobases (28–32). Thus, the newly–designed thioguanines, especially 3a, could outstrip 
the thio–analogues of nucleobases examined so far in terms of their absorption properties. 
Photochemical experiments should be carried out in rigidly dehydrated organic solvents to 
clarify the intrinsic property of the excited states for the thio–nucleobases, however, purine 
nucleobases have generally low solubility in most of organic solvents (33). Thus, we prepared 
tri–acetyl–protected derivatives (1c–4c) for better solubility and easier handlings.  
In this article, we report our work on chemical synthesis and photochemical investigation 
of thiolated guanine derivatives (1c, 2c and 3c). We also present out results on their structural 
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characterizations by NMR, absorption properties by steady–state absorption spectra and 
quantum yields of 
1
O2
*
 generation by time–resolved near–infrared emission measurement. It 
is our view that these thioguanosine derivatives can be further developed as a potential 
photochemotherapeutic agent. 
 
MATERIALS AND METHODS  
General. Reagents were purchased from standard suppliers and used without further 
purification. Solvents were used after distillation. Reactions were monitored with thin−layer 
chromatograph (TLC) plate (Silica gel 60, F254). Spots on the TLC plate were monitored 
with UV, ninhydrin or anisaldehyde. A C–200 Silica gel was used for silica gel flash 
chromatography. 
1
H NMR and 
13
C NMR spectra were measured with 500 MHz NMR (JEOL, 
JNM−ECX 500 MHz), and typical 1H NMR and 13C NMR spectra are shown in the 
Supporting Information (Figures S1–S8). The multiplicity was expressed as follows; s = 
singlet, d = doublet, t = triplet, m = multiplet, br = broad. The chemical shifts are expressed in 
ppm relative to residual solvent as an internal standard, and coupling constants (J values) 
were represented in hertz. Mass spectrum was measured by using FAB–MS (JEOL, JMS–700 
MStation). 
Synthesis of 2’,3’,5’−tri−O−acetylguanosine (4c). Acetic anhydride (9 mL, 95.2 mmol) 
was added to a solution of guanosine (4b, 2.83g, 10.0 mmol) in pyridine (27 mL), and the 
mixture was kept for 2 h at 80 °C. The reaction was quenched by addition of H2O at 0 °C 
after checking the completion of the reaction by TLC. The reaction mixture was dissolved in 
ethyl acetate and washed with saturated NH4Cl, and the organic layer was dried with 
anhydrous magnesium sulfate. After evaporation of the solvent and column chromatography 
(CH2Cl2/MeOH = 9:1), 2’,3’,5’−tri−O−acetylguanosine (4c, 2.21 g, 5.40 mmol, 54%) was 
obtained as white solid. Rf = 0.40 (CH2Cl2/MeOH = 9:1): 
1
H NMR (500 MHz, 
dimethylsulfoxide−d6) (δ, ppm) 10.76 (1H, s), 7.89 (1H, s), 6.55 (2H, br s), 5.95 (1H, d, J = 
6.2 Hz), 5.75 (1H, t, J = 5.5 Hz), 5.46 (1H, dd, J = 5.8, 4.5 Hz), 4.34 (1H, dd, J = 13.8, 4.1 
Hz), 4.29−4.26 (1H, m), 4.22 (1H, dd, J =11.7, 5.5 Hz), 2.07 (3H, s), 2.00 (3H, s), 1.86 (3H, 
s); 
13
C NMR (125 MHz, dimethylsulfoxide−d6) (δ, ppm) 170.6, 170.0, 169.8, 157.2, 154.5, 
151.6, 136.2, 117.3, 84.9, 80.1, 72.6, 70.8, 63.6, 21.1, 20.9, 20.7.  
Synthesis of 2’,3’,5’−tri−O−acetyl−6−thioguanosine (1c). Lawesson’s reagent (1.19 g, 
2.93 mmol) was added to a solution of 2’,3’,5’−tri−O−acetylguanosine (4c, 2.01 g, 4.91 
mmol) in dioxane (40 mL), and the mixture was kept for 5 h at +100°C. The reaction mixture 
was dissolved in ethyl acetate and washed with saturated NaHCO3, and the organic layer was 
dried with anhydrous magnesium sulfate. After evaporation of the solvent and column 
chromatography (CH2Cl2/MeOH = 97:3), 2’,3’,5’−tri−O−acetyl−6−thioguanosine (1c, 0.999 
g, 2.35 mmol, 48%) was obtained as white solid. Rf = 0.51 (CH2Cl2/MeOH = 9:1):
 1
H NMR 
(500 MHz, dimethylsulfoxide−d6) (δ, ppm) 12.03 (1H, s), 8.09 (1H, s), 6.84 (2H, s), 5.95 (1H, 
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d, J = 6.2 Hz), 5.76 (1H, t, J = 6.2 Hz), 5.45 (1H, dd, J = 6.2, 4.1 Hz), 4.34 (1H, dd, J = 11.3, 
3.7 Hz), 4.30 (1H, dd, J = 9.6, 4.1 Hz), 4.23 (1H, dd, J =11.0, 5.5 Hz), 2.07 (3H, s), 2.00 (3H, 
s), 1.99 (3H, s); 
13
C NMR (125 MHz, dimethylsulfoxide−d6) (δ, ppm) 176.0, 170.0, 169.9, 
169.8, 153.7, 148.2, 139.0, 128.9, 85.1, 80.2, 72.5, 70.8, 63.5, 21.1, 20.9, 20.7. 
Synthesis of 8−bromoguanosine (5). Br2 (3.0 mL) was added to a suspension liquid of 
guanosine (4b, 5.0 g, 17.7 mmol) in H2O (100 mL), and the vigorous stirring was kept for 24 
h at room temperature. Excess Br2 was quenched by addition of saturated sodium thiosulfate 
solution (3.0 mL), the precipitate was collected by filtration and washed by H2O on a 
Buchner funnel. After evaporation of the solvent, 8−bromoguanosine (5, 6.3 g, 17.5 mmol, 
99%) was obtained as white solid. 
Synthesis of 8−thioguanosine (2b). Thiourea was added to a suspension liquid of 
8−bromoguanosine (5, 4.01 g, 11.1 mmol) in ethanol (40 mL). A small quantity of H2O 
(5mL) was added until the suspension liquid being dissolved, and kept heated to reflux for 24 
h. The reaction mixture was cooled at room temperature, excess ethanol was evaporated and 
the precipitated solid was filtered. The solid was washed with H2O on a Buchner funnel, and 
after evaporation of the solvent, 8−thioguanosine (2b, 2.39 g, 7.59 mmol, 68%) was obtained 
as white solid. 
Synthesis of 2’,3’,5’−tri−O−acetyl−8−thioguanosine (2c). Acetic anhydride (2 mL, 21.2 
mmol) was added to a solution of 8−thioguanosine (2b, 2.10 g, 6.69 mmol) in pyridine (35 
ml), and the mixture was kept for 8 h at room temperature. The reaction was quenched by 
addition of H2O at 0°C after checking the completion of the reaction by TLC. The reaction 
mixture was dissolved in ethyl acetate and washed with saturated NH4Cl, and the organic 
layer was dried with anhydrous magnesium sulfate. After evaporation of the solvent and 
column chromatography (CH2Cl2/MeOH = 95:5), 2’,3’,5’−tri−O−acetyl−8−thioguanosine (2c, 
1.76 g, 3.98 mmol, 59%) was obtained as white solid. Rf = 0.46 (CH2Cl2/MeOH = 9:1):
 
1H−NMR (500 MHz, dimethylsulfoxide−d6) 13.02 (1H, br), 11.09 (1H, br), 6.62 (2H, br), 
6.38 (1H, s), 6.10 (1H, br), 5.63 (1H, t, J = 6.0 Hz), 4.38 (1H, dd, J = 11.7, 3.4 Hz), 4.20 (1H, 
m), 4.17 (1H, dd, J = 11.3, 6.5 Hz) 2.06 (3H, s), 2.02 (3H, s), 1.97 (3H, s); 
13C−NMR (125 
MHz, dimethylsulfoxide−d6) 170.7, 169.88, 169.82, 165.5, 154.4, 151.4, 149.7,104.4, 86.8, 
79.5, 71.3, 70.7, 63.5, 21.0, 20.8, 20.7. 
Synthesis of 2’,3’,5’−tri−O−acetyl−8−bromoguanosine (6). Acetic anhydride (5 mL, 52.9 
mmol) was added to a solution of 8−bromoguanosine (5, 4.76 g, 13.2 mmol) in pyridine (29 
mL), and the mixture was kept for 6 h at room temperature. The reaction was quenched by 
addition of H2O at 0°C after checking the completion of the reaction by TLC. The reaction 
mixture was dissolved in ethyl acetate and washed with saturated NH4Cl, and the organic 
layer was dried with anhydrous magnesium sulfate. After evaporation of the solvent and 
column chromatography (CH2Cl2/MeOH = 95:5), 2’,3’,5’−tri−O−acetyl−8−bromoguanosine 
(6, 4.79 g, 9.84 mmol, 75%) was obtained as white solid. Rf = 0.48 (CH2Cl2/MeOH = 9:1). 
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Synthesis of 2’,3’,5’−tri−O−acetyl−6,8−dithioguanosine (3c). Lawesson’s reagent (8.75 g, 
21.6 mmol) was added to a solution of 2’,3’,5’−tri−O−acetyl−8−bromoguanosine (6, 5.00 g, 
10.3 mmol) in dioxane (100 mL), and the mixture was kept for 4 h at +100°C. The reaction 
mixture was dissolved in ethyl acetate and washed with saturated NaHCO3, and the organic 
layer was dried with anhydrous magnesium sulfate. After evaporation of the solvent and 
column chromatography (CH2Cl2/MeOH = 97:3), 2’,3’,5’−tri−O−acetyl−6,8−thioguanosine 
(3c, 2.33 g, 5.10 mmol, 50%) was obtained as yellow solid. Rf = 0.54 (CH2Cl2/MeOH = 9:1): 
1H−NMR (500 MHz, dimethylsulfoxide−d6) 13.11 (1H, br), 12.21 (1H, br), 6.93 (2H, br), 
6.40 (1H, d, J = 4.1 Hz), 6.08 (1H, t, J = 5.5 Hz), 5.60 (1H, t, J = 6.2 Hz), 4.38 (1H, dd, J = 
11.7, 6.9 Hz), 4.22 (1H, m), 4.16 (1H, dd, J = 11.7, 6.9 Hz), 2.06 (3H, s), 2.02 (3H, s), 1.97 
(3H, s): 
13C−NMR (125 MHz, dimethylsulfoxide−d6) 170.6, 169.88, 169.84, 168.1, 164.1, 
154.1, 146.7, 117.8, 86.8, 79.6, 71.1, 70.7, 63.5, 21.1, 20.8, 20.7: MS (FAB+) m/z 458 (MH
+
). 
Ultraviolet−visible (UV−vis) absorption spectroscopy. The UV−vis absorption spectra 
were recorded at room temperature on a spectrophotometer (JASCO, U–best V550) using a 
quartz cuvette of 1 cm optical path length. The sample solution was prepared with acetonitrile 
as a solvent.  
Time–resolved near–infrared emission spectroscopy. Time–resolved near–infrared 
emission measurement was carried out with a thermoelectric cooled near–infrared 
photomultiplier tube (Hamamatsu Photonics, H10330–45; InP/InGaAsP, spectral response 
950 to 1400 nm) combined with a longpass filter (Thorlabs, FEL1250; cut–on wavelength 
1250 nm) and a bandpass filter (Edmund, Hard–coated bandpass filter; 1275 ± 50 nm) 
(Figure S9). A forth harmonic of a Nd
3+
:YAG laser (Continuum, Surelite II–10, 5 ns pulse 
duration, 10 Hz, 266 nm) was used as an excitation light source. The sample solution was 
prepared with acetonitrile as a solvent. 
Quantum chemical calculation. Ground− and excited−state calculations for corresponding 
purine bases (1a−4a) were performed using the Gaussian 09W program package (30). 
Ground−state geometries of the purine bases were optimized by the density functional theory 
(DFT) at the B3LYP/6−311+G(d,p) level. Vertical excitation energies were estimated by the 
time−dependent DFT (TD−DFT) at the TD−B3LYP/6−311+G(d,p) level. Solvent effects 
were modeled with the polarizable continuum model (PCM) for the ground− and 
excited−states. 
 
RESULTS AND DISCUSSION  
Synthesis of thioguanosine derivatives 
 Scheme 2 outlines the synthetic route to 1c−4c. The syntheses of 1c, 2c and 4c have been 
reported previously (35−44). To the best of our knowledge, this is the first report on chemical 
synthesis of 3c. The structures of all synthesized products were characterized by 
1
H NMR 
and their purities were estimated to be 99% for 1c, 99% for 2c, 99% for 3c, and 97% for 4c 
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with a minor amount of impurity being H2O. The concentration of H2O was determined by 
subtracting the peak area deriving from H2O in dimethylsulfoxide–d6 solvent from that in 
1c–4c solutions to remove the intrinsic moisture content of the deuterated solvent. No other 
impurity was detected by HPLC spectra as shown in Figure S10. 
 
>Scheme 2< 
 
1c was prepared in a 2−step process for the first time. First, 4b was quantitatively 
converted to 4c, which then was transformed to 1c with Lawesson’s reagent. Following the 
reported procedure (21,43,44), 2c was synthesized in a 3−step process from 4b. To prepare 3c, 
6 is the key intermediate which can be obtained from bromination of 4b followed by 
acetylation of the resultant 5 in an excellent yield (23,44). In an early report (23), 6 had been 
treated with phosphoryl chloride and hydrolyzed to afford 2–amino–6,8–dichloro purine, 
followed by nucleophilic substitution reaction with thiourea to yield 3b. In order to overcome 
the difficulty in handling the phosphoryl chloride and its low yield of 3b (33%) (23), thus, we 
developed another synthetic route to 3c. By a simple treatment of 6 with Lawesson’s reagent, 
3c was successfully afforded with a higher yield of 50%. 
 
1
H and 
13
C NMR analysis of thioguanosine derivatives 
  To ascertain the correct structures of the synthesized products, NMR spectroscopy was 
used. The 
1
H NMR chemical shifts of 1c–4c are listed in Table 1. The chemical shift values 
for the proton at 1–position (the imide group) of thioguanosine derivatives were observed at 
lower magnetic field than that of un–thiolated guanosine. The peaks for the imide group, 
especially in 1c and 3c, were significantly shifted to a lower magnetic field. This shift can be 
ascribed to the thiocarbonyl substitution at 6−position of the purine ring. The thiocarbonyl 
modification at 8−position also causes a significant shift of the peak for the imide group to a 
lower magnetic field, as observed for 2c. The peaks for the amine protons at 2−position of the 
purine ring for 1c and 3c also exhibited a slight shift to the low field in comparison with the 
corresponding peak for 2c and 4c. The chemical shift values deriving from ribose sugar 
protons, especially for anomeric proton (1’H), were also shifted to a lower magnetic field in 
both 2c and 3c. These shifts can be ascribed to the thiocarbonyl modification at 8−position, 
consistent with a recent publication in which the peak for the proton at 3–position (the imide 
group) in 4–thio−pyrimidines was also found to be at lower magnetic field than that of 
un–thiolated pyrimidine bases (45). 
 
  Table 2 lists 
13
C NMR chemical shifts of all the carbon atoms in compounds 1c–4c. The 
peak at 157.2 ppm in un–thiolated 4c was found to shift to 176.0 ppm (18.8 ppm lower 
magnetic field) in the 6–thiolated analogue (1c). Similarly, the peak at 136.2 ppm in the 
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un–thiolated 4c was also found to shift substantially to 165.5 ppm in the 8–thiolated analogue 
(2c), resulting 29.3 ppm lower magnetic field shift. Compound 3c is a doubly thiolated 
analogue, both of the thio–carbonyl carbons are shifted to a lower field (i.e.168.1 and 164.1 
ppm) compared with those of un–thiolated 4c. These shifts should be due to the thiolation at 
their respective positions (6–posiotn and 8–position). The similar effect was also reported for 
the carbon atoms of thio−carbonyl carbons in 2−thiouracil and 4−thiouracil (45,46). 
 
UV−vis absorption spectroscopy 
 The absorption spectra of 1c, 2c, 3c and 4c are shown in Figure 1a. Absorption spectrum of 
4c, appeared in the spectral range less than 295 nm, was almost identical to that of guanosine 
(4b), revealing that the acetylation of three hydroxyl groups in the sugar component had little 
effect on electronic states concerning with transitions in this spectral range. Since the 
solubility of 4c (tri–acetyl protected guanosine) in acetonitrile was over 300 times larger than 
that of 4b (un–protected guanosine) in units of molarity (16.5 mM for 4c and 41.6 µM for 4b), 
thus corresponding tri–actyl protected analogues instead of the un–protected analogue were 
used to study their UV properties. The absorption spectrum for 2c (8–thiolated analogy) 
exhibited an intense absorption band centered at 302 nm with a high molar absorption 
coefficient [   
       = (2.39 ± 0.01) × 10
4
 M
–1
 cm
–1
]. In comparison with 4c, this red–shift of 
the band (48 nm) observed from 2c is likely to result from the extension of the π–conjugation 
due to the thiocarbonyl modification at 8–position of the purine ring. 1c (6–thiolated analogy) 
has a much large red–shifted band (91 nm) with a higher molar absorption coefficient 
[   
       = (2.82 ± 0.01) × 10
4
 M
–1
 cm
–1
]. The absorption maximum of 1c appeared in the 
longer wavelength region than that of 2c, indicating that thio–carbonyl modification at 
6–position has more contribution to its electronic transition than that at 8–position. Our 
findings offer a solid support to an early report (17) that the replacement of an oxygen atom 
by a sulfur atom in a carbonyl group is expected to shift the absorption band to the red. The 
absorption maximum of 3c (di–thiolated analogue) was observed at 381 nm, which 
surprisingly results in a red–shift up to 126 nm in comparison with 4c. In addition, the 
absorption intensity at the maximum [   
       = (3.76 ± 0.02) × 10
4
 M
–1
 cm
–1
] was 
remarkably higher than any other thio–analogues of nucleobases examined so far 
(3,15–19,28–32), revealing 3c can be irradiated with a very low dose of UV light. These 
desirable UV properties suggest that 3c would be much sensitive to the light penetrating into 
the human skin and could be used as a powerful photosensitive agent for light–induced 
therapies, including PDT. Thioguanosines (1c, 2c and 3c) are not regarded as suitable agents 
for PDT because of the absence of one–photon absorption at visible light. However, in our 
recent works (47,48), 1b and 3c were successfully excited at red light by multi–photon 
excitation. Thus, with the multi–photon approach, thioguanosines have offered a potential as 
a PDT sensitizer.  
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  Steady–state emission measurements were also carried out on 1c–3c, but no emission was 
observed at room temperature, indicating a fluorescence quantum yield of virtually zero. On 
the other hand, emission was clearly observed at 77 K in glassy ethanol matrix, as described 
in the supporting materials (Figure S11). Those emission bands exhibited significantly large 
Stokes shift from those absorption maxima (beyond 100 nm, as listed in Table 3) with long 
life times, over a microsecond. The emission spectrum of 1c was identical to the reported 
phosphorescence spectrum of 1b (49,50). Although the quantum yields of triplet formation 
for these thioguanosines (1c, 2c and 3c) have not been obtained yet, their triplet–triplet 
absorption spectra were observed at room temperature, which will be described in detail in 
the next paper. In addition, these thioguanosines have relatively high quantum yields of 
singlet molecular oxygen generation (see below), indicating high triplet formation of these 
compounds. Therefore, those emissions can be confidently assigned to their respective 
phosphorescence of 1c–3c. Thus, 2c and 3c as well as 1a–1c will form the excited triplet 
manifold through intersystem crossing from the singlet excited states. 
 
 
  Quantum Chemical Calculations 
Optimized ground–state geometries of 1a, 2a and 3a are shown in Figure S12. These 
molecules belong to the Cs symmetry, and all atoms lie in a plane of the purine ring. The 
bond lengths and angles were comparable to each other except for the C
6
=S and C
6
=O bond 
lengths. The C
6
=S bond lengths of 1a and 3a (1.69 Å) were significantly larger than the C
6
=O 
bond lengths of 2a and 4a (1.23 Å). This clearly reveals that the strength of the C
6
=S bond is 
weaker than that of the C
6
=O bond. 
  Computational vertical transition energies and oscillator strengths of 1a–3a are shown in 
Figure 1b, and listed in Table 3. The calculated vertical transition energies and oscillator 
strengths of 1a–3a well reproduce the red–shifted absorptions of 1c–3c in comparison with 
4c. 
Molecular orbitals involved in the transitions to first and second excited singlet states of 
1a–3a are shown in Figure 2. In all compounds, HOMO–1 has n character with electronic 
density localized around the sulfur atom perpendicularly to the molecular plane whereas both 
HOMO and LUMO have π and π* character with extended electronic density throughout the 
molecular plane, respectively. For 1a, the first excited singlet (S1) state arises from the 
transition from the n orbital localized on the sulfur atom (HOMO–1) to the π* orbital 
(LUMO), and the calculated small oscillator strength (f < 0.0001) indicates the forbidden 
S1(nπ
*)←S0 transition. On the other hand, the transition to the second excited singlet (S2) 
state is the allowed ππ* transition (HOMO → LUMO) (f = 0.571). Thus, the intense 
absorption band of 1c around 346 nm would be attributed to the S2(ππ
*
)←S0 transition. For 
2a and 3a, the transition to the S1 and S2 states arise from the allowed ππ
*
 transition (HOMO 
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→ LUMO) and forbidden nπ* transition (HOMO–1 → LUMO). Thus, the absorption peak at 
the longest wavelength of 2c and 3c would be attributed to the S1(ππ
*
)←S0 transition. The π 
and π* orbitals of 2a and 3a were widely extended to the 8–position of the purine ring as 
shown in Figure 2, resulting in the red–shifted absorption of 2c and 3c with respect to 4c and 
1c, respectively. 
 
For 1a–3a, the T1 state was also optimized and shown in Figure S13. The optimized 
structures for 1a–3a at the T1 state are also comparable to that at ground–state except for the 
S
6
 atom of 1a at the T1 state (only the S
6
 atom is out of molecular plane). The optimized 
structures for 1a–3a at the T1 state can be assigned to the ππ
*
 state, as shown in Figure S14. 
The T1 state energies of 1a–3a are listed in Table 3. The calculated T1 energies well agree 
with the experimental values, estimated from the maximum emission wavelength in the 
phosphorescence spectra of 1c–3c.  
 
Time–resolved near–infrared emission spectroscopy 
The quantum yield of singlet oxygen generation for the thioguanosines was determined for 
exploration of these potential drugs in photochemotherapy. Figure 3a shows the decay 
profiles of singlet oxygen phosphorescence measured at around 1275 nm by 
photosensitization with 1c, 2c, and 3c in O2 saturated acetonitrile solutions. All signals 
decayed mono–exponentially and their lifetimes were about 65 µs, well agreeing to the 
lifetime of 
1
O2
*
 in acetonitrile (51,52). Since this signal was not detectable in Ar saturated 
solutions, the emission should be due to 
1
O2
*
, generated by photosensitization with 
thioguanosines. 
 
The quantum yields of 
1
O2
*
 generation of thioguanosines were determined in O2 saturated 
acetonitrile solutions relative to optically matched phenalenone (PN) solution (ΦΔ = 1.00 ± 
0.03) (53). Individual phosphorescence traces were fitted by using a single–exponential 
function to estimate the emission intensity maxima immediately after laser irradiation (IS
0
). 
The IS
0
 value was plotted against the laser fluence (IL) (Figure 3b). A good linear relationship 
was observed between IS
0
 and IL. This finding reveals that 
1
O2
*
 was generated by one–photon 
process through photosensitization by thioguanosines. The values of the slope obtained from 
these plots (IS
0
 / IL) were plotted against the ground–state absorptance at excitation 
wavelength (1–10–A), as shown in Figure 3c. These plots also show good linear relationships. 
By comparing the slopes of thioguanosines with that of PN, we were able to determine ΦΔ 
values, with a high degree of accuracy, as 0.37 ± 0.01 for 1c, 0.28 ± 0.01 for 2c and 0.33 ± 
0.01 for 3c. The ΦΔ value for 1c was close to those for 1a and 1b in the previous report 
(18,20). These results further confirm that those thioguanosines generate 
1
O2
*
 effectively 
through photosensitization.  
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It was noted that there are only very small differences in the ΦΔ values among the 
thioguanosines (see Table 3). 
1
O2
*
 is considered to generate through energy transfer from the 
T1 state of donor molecule to an oxygen molecule (X
3Σg
–
) as an energy acceptor by collision 
each other, thus the ΦΔ value should depend on the following factors: the intersystem 
crossing quantum yield, the triplet lifetime of the sensitizer and the SΔ value (a fraction of the 
triplet states quenched by dissolved oxygen which gives rise to singlet oxygen formation). 
Generally, triplet states of ππ* have been reported to give a SΔ value of a range of 0.7–1.0, 
whereas it is ~0.3 for nπ* triplet states (54). All the T1 state of 1c, 2c and 3c have ππ
*
 
character in the Franck–Condon region obtained by the TD–DFT calculation, and its T1 
energies are large enough to surpass vertical transition energy of oxygen molecules (0.97 eV; 
a
1Δg ← X
3Σg
–
), as discussed above. Therefore, the differences in ΦΔ will depend on the 
lifetime of each T1 state and/or quantum yields of intersystem crossing to triplet manifolds. 
To gain the more detailed information on the triplet state such as lifetime and quantum yield, 
time–resolved spectroscopy are under way. 
 
CONCLUSION 
  Three novel thioguanosine derivatives (1c–3c) have been successfully synthesized and 
characterized by various spectroscopies. The absorption bands of these thioguanosines are 
found to be at longer wavelengths than those of un–thiolated guanosines (4b and 4c). 
Especially, 3c has the most red–shifted band with a large molar absorption coefficient, 
indicating that 3c is much sensitive to the light penetrating into the human skin. The 
red–shifted spectra for thio–analogues were well reproduced with the quantum chemical 
calculations. The T1 character was found to be a ππ
*
 character. In addition, the thioguanosines 
generated 
1
O2
*
 effectively through photosensitization (ΦΔ = 0.28~0.37). Taken together, these 
results clearly show that our reported thioguanosines have some potential for 
photochemotherapy, as a photoactivatable genotoxic agent and/or a photosensitizer for PDT. 
Although the SΔ value for the T1 (ππ
*
) was known to be high, the small difference in ΦΔ 
values among the thioguanosines is likely to be dependent on the intersystem crossing 
quantum yield and/or T1 state lifetime of each individual thioguanosine. 
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Figure S4.  
13
C NMR spectrum of 2c in dimethylsulfoxide–d6 solution. 
Figure S5.  
1
H NMR spectrum of 3c in dimethylsulfoxide–d6 solution. 
Figure S6.  
13
C NMR spectrum of 3c in dimethylsulfoxide–d6 solution. 
Figure S7.  
1
H NMR spectrum of 4c in dimethylsulfoxide–d6 solution. 
Figure S8.  
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Figure S9.  Schematic diagram of the experimental setup for the time–resolved near IR 
emission measurement. 
Figure S10.  HPLC chart for (a) 1c, (b) 2c, (c) 3c and (d) 4c. The ratio of eluents (water and 
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300 nm for 2c, 370 nm for 3c and 260 nm for 4c. Retention times: 1c 8.6 min; 2c 10.73 min; 
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 = 0.4) 1c, 
2c, and 3c glassy ethanol matrix measured at 77 K. The spectrum of 2c was 10 times 
multiplied. 
Figure S12.  Optimized structures at the ground state of 1a, 2a, and 3a. 
Figure S13.  Optimized structures at the triplet state of 1a, 2a, and 3a. 
Figure S14.  Molecular orbitals at the T1 state of 1a, 2a and 3a. 
Table S1. Cartesian coordinates for optimized structure at the ground state of 1a. 
Table S2. Cartesian coordinates for optimized structure at the ground state of 2a. 
Table S3. Cartesian coordinates for optimized structure at the ground state of 3a. 
Table S4. Cartesian coordinates for optimized structure at the T1 state of 1a. 
Table S5. Cartesian coordinates for optimized structure at the T1 state of 2a. 
Table S6. Cartesian coordinates for optimized structure at the T1 state of 3a. 
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Table 1. 
1
H NMR Chemical Shifts of 1c–4c. 
 
N1H N7H N2H2 1' 2' 3' 4' 5' 5' 
1c 12.03 − 6.84 5.95 5.76 5.45 4.30 4.34 4.23 
2c 11.09 13.02 6.62 6.38 6.10 5.63 4.20 4.38 4.17 
3c 12.21 13.11 6.93 6.40 6.08 5.60 4.22 4.38 4.16 
4c 10.76 − 6.55 5.95 5.75 5.46 4.27 4.34 4.22 
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Table 2. 
13
C NMR Chemical Shifts of 1c–4c. 
 C
2 
C
4
 C
5
 C
6
 C
8
 1’ 2’ 3’ 4’ 5’ 
1c 153.7 148.2 128.9 176.0 139.0 85.1 80.2 72.5 70.8 63.5 
2c 151.4 154.4 104.4 149.7 165.5 86.8 79.5 71.3 70.7 63.5 
3c 146.7 154.1 117.8 168.1 164.1 86.8 79.6 71.1 70.7 63.5 
4c 154.5 151.6 117.3 157.2 136.2 84.9 80.1 72.6 70.8 63.6 
 
Table 3. Photophysical Properties of 1c, 2c and 3c in Acetonitrile Solution. 
†
 
Wa
vel
eng
th 
at 
abs
orption maximum. 
§
 Molar absorption coefficient at absorption maximum. 
‖
 Triplet state 
energy obtained from emission peak of phosphorescence spectrum. 
¶
 Quantum yield of 
singlet oxygen generation. 
#
 Vertical transition energy. 
**
Oscillator strength. 
††
 Triplet state 
energy. 
‡‡
 Calculated at the PCM/TD–B3LYP/6–311+G(d,p) level.  
  
 Experimental  Computational
‡‡ 
 λmax
† / nm εmax
§ / 104 M–1 cm–1 ET 
‖ / eV ΦΔ
¶ Es
# / nm f ** ET
†† / eV 
1c 346 2.82 ± 0.01 2.71 0.37 ± 0.01 338 0.571 2.70 
2c 302 2.39 ± 0.01
 2.93 0.28 ± 0.01 312 0.497 3.04 
3c 381 3.76 ± 0.02 2.50 0.33 ± 0.01 383 0.669 2.43 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
Scheme 1. Structures of guanine, thioguanines, and their nucleosides. 
 
 
 
 
Scheme 2. The synthesis route for thioguanosine and guanosine derivatives. 
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FIGURE CAPTIONS 
Figure 1. (a) Absorption spectra of 1c–4c in acetonitrile solution, and (b) Computational 
vertical transition energy and oscillator strength of 1a–4a at PCM/TD–B3LYP/6–311G+(d,p) 
level. 
 
Figure 2. Molecular orbitals involved in transitions to the first and second excited single 
states of 1a, 2a and 3a. 
 
Figure 3. (a) Decay profiles of singlet oxygen phosphorescence measured at around 1275 nm 
of thioguanosines and PN in acetonitrile solution. Signals are corrected for absorptance at 
excitation wavelength (266 nm) and incident laser power. (b) Plots of the emission intensity 
maxima (IS
0
) immediately after laser irradiation in 3c solutions against incident laser power 
(IL), and (c) plots of the IS
0
/IL value of 1c, 2c, 3c, and PN against the absorptance (1–10
–A
) at 
excitation wavelength (266 nm). 
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